| 영문 | granulocyte | 한글 | 과립구 |
|---|---|---|---|
| 설명 | 과립구란 적혈구를 제외한 혈액속의 세포인 백혈구의 60%를 차지하며, 세포속에 특이한 과립을 가지고 있는 세포이며, 다음과 같은 3가지의 세포가 이곳에 포함이 된다. 1. 호염기구(basophil)-염기성 염색약에 잘 염색이 되는 과립을 가지고 있다. 불규칙한 모양의 세포로 푸른색을 띠는 과립이 너무 많이 있어서 핵이 잘 보이지 않는다. 2. 호산구(eosinophil)-산성 염색약에 잘 염색이 되는 과립을 가지고 있고, 대개 기생충의 감염이나, 알레르기에서 많이 증가를 한다. 대개 2개의 핵을 가지고 있으며 핵사이에 가는 실같은 것으로 이어져 있다. 3. 호중구(neutrophil)-산성 염색약이나 염기성 염색약이나 모두 잘 되는 과립을 가지는 세포로 대개 3개의 핵을 가진다. 그리고 핵 사이에 가는 실같은 구조물이 있어서 핵을 서로 이어주고 있다. 이 과립구는 주로 면역에 관계된 역할을 하는 것으로 알려져 있다. |
||
| 영문 | segmented granulocyte | 한글 | 분절 과립구 |
|---|---|---|---|
| 설명 | 과립구(세포질내에 점같은 과립을 포함하는 세포)중 말초 혈액을 순환하는 성숙된 과립구로 핵의 모양이 두 개 이상의 분절을 이루고 있다. 여기에는 그 염색상의 방법에 따라 호중구(중성에서 과립염색을 보임), 호산구(산성에서 과립염색을 보임), 호염구(염기성에서 과립염색을 보임)로 나뉜다. |
||
| SSD | shaded surface display; single saturating dose; Social Security disability; source-skin distance; so... |
|---|---|
| MGP | marginal granulocyte pool; marginating granulocyte pool; membranous glomerulonephropathy; mucin glyc... |
| CSO | claims services only; common source outbreak; craniostenosis; craniosynostosis; ostium of coronary s... |
| MSI | magnetic source imaging; medium-scale integration |
| SAD | Scale of Anxiety and Depression; seasonal affective disorder; Self-Assessment Depression [scale]; se... |
| GM-CSF | Granulocyte colony-stimulating factor , granulocyte-macrophage colony-stimulating factor |
|---|---|
| G-CSF | Granulocyte-Macrophage Colony-Stimulating Factor , Granulocyte Colony-Stimulating Factor |
| BESA | Brain electric source analysis |
| CSD | Current Source Density |
| MSI | Magnetic Source Imaging |
| carbon source | Any carbon-containing organic molecule (carbohydrate, aminoacid) that an organism can use to produce energy in the form of ATP. (09 Oct 1997) |
|---|---|
| major source | A source that emits, or has the potential to emit, a pollutant regulated under the Clean Air act in excess of a specified rate in a nonattainment area. (05 Dec 1998) |
| receptors, granulocyte-colony-stimulating factor | Receptors that bind and internalise granulocyte-colony-stimulating factor. Their mw is believed to be 150 kD. These receptors are found mainly on a subset of myelomonocytic cells. (12 Dec 1998) |
| receptors, granulocyte-macrophage colony-stimulating factor | Receptors that bind and internalise the granulocyte-macrophage stimulating factor. Their mw is believed to be 84 kD. The most mature myelomonocytic cells, specifically human neutrophils, macrophages, and eosinophils, express the highest number of affinity receptors for this growth factor. (12 Dec 1998) |
| granulocyte | <haematology> Leucocyte with conspicuous cytoplasmic granules. In humans the granulocytes are also classified as polymorphonuclear leucocytes and are subdivided according to the staining properties of the granules into eosinophils, basophils and neutrophils (using a Romanovsky type stain), some invertebrate blood cells are also referred to, not very helpfully, as granulocytes. (12 Dec 1998) |
| granulocyte-colony-stimulating factor | <growth factor, haematology, oncology> A glycoprotein of 25 kD containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukaemic myeloid cell lines. A protein that stimulates the growth and maturation of granulocytes. It is used to promote the recovery of the white cells following chemotherapy. See: colony-stimulating factor. Acronym: G-CSF (12 Dec 1998) |
| granulocyte-macrophage colony-stimulating factor | <growth factor, haematology, oncology> An acidic glycoprotein of mw 23 kD with internal disulfide bonds. It is produced in response to a number of inflammatory mediators by mesenchymal cells present in the haemopoietic environment and at peripheral sites of inflammation. It stimulates the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from foetal liver progenitor cells. It also has some functional activities in mature granulocytes and macrophages. It is used to promote the recovery of the white blood cells following chemotherapy. Chemical name: Colony-stimulating factor 2 See: colony-stimulating factor. Acronym: GM-CSF (12 Dec 1998) |
| common-source epidemic | <microbiology> An epidemic resulting from infection of a large number of people from a single contaminated source. (09 Oct 1997) |
| point source | In photometry, a very small source of light which is regarded as a geometrical point from which light emanates in straight lines in all directions. (05 Mar 2000) |
| power source | Devices that supply energy. (12 Dec 1998) |
| source emission reduction plan | (SERP) A contingency plan developed to reduce emissions during an air quality emergency. (05 Dec 1998) |
| immature granulocyte | An immature neutrophil, except that it may be neutrophilic, acidophilic, or basophilic in character. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|